IRIS
OYEN, Willem Jozef Gerard
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.813
AS - Asia 21.248
EU - Europa 5.454
SA - Sud America 2.915
AF - Africa 1.237
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 19
Totale 71.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.253
SG - Singapore 15.403
BR - Brasile 2.460
CN - Cina 1.998
VN - Vietnam 1.968
FI - Finlandia 1.375
IE - Irlanda 1.067
NG - Nigeria 915
FR - Francia 641
DE - Germania 631
HK - Hong Kong 433
NL - Olanda 415
GB - Regno Unito 399
CA - Canada 341
IT - Italia 281
IN - India 262
TR - Turchia 178
BD - Bangladesh 175
AR - Argentina 162
IQ - Iraq 130
MX - Messico 122
RU - Federazione Russa 116
SE - Svezia 112
IL - Israele 106
ZA - Sudafrica 92
PK - Pakistan 88
PL - Polonia 67
ES - Italia 63
JP - Giappone 61
UA - Ucraina 58
VE - Venezuela 55
EC - Ecuador 53
CL - Cile 50
MA - Marocco 50
CO - Colombia 49
ID - Indonesia 46
AU - Australia 45
KE - Kenya 45
UZ - Uzbekistan 45
SA - Arabia Saudita 41
JO - Giordania 34
EG - Egitto 30
IR - Iran 30
PH - Filippine 30
AE - Emirati Arabi Uniti 29
PY - Paraguay 29
TN - Tunisia 28
DZ - Algeria 27
CZ - Repubblica Ceca 24
MY - Malesia 23
NP - Nepal 23
RO - Romania 23
AT - Austria 22
AZ - Azerbaigian 22
BO - Bolivia 21
PE - Perù 20
OM - Oman 19
JM - Giamaica 18
KZ - Kazakistan 17
LB - Libano 16
MD - Moldavia 15
UY - Uruguay 15
BE - Belgio 14
CH - Svizzera 14
DO - Repubblica Dominicana 14
GR - Grecia 14
LT - Lituania 14
SN - Senegal 14
A2 - ???statistics.table.value.countryCode.A2??? 13
NZ - Nuova Zelanda 13
CR - Costa Rica 12
PA - Panama 12
AL - Albania 11
ET - Etiopia 11
HN - Honduras 11
PS - Palestinian Territory 11
RS - Serbia 11
DK - Danimarca 9
PT - Portogallo 9
BH - Bahrain 7
NI - Nicaragua 7
QA - Qatar 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
BY - Bielorussia 6
HU - Ungheria 6
KR - Corea 6
NO - Norvegia 6
BB - Barbados 5
CI - Costa d'Avorio 5
HR - Croazia 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
GE - Georgia 4
GT - Guatemala 4
KW - Kuwait 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
GD - Grenada 3
Totale 71.682
Salva come PNG Salva come JPEG
Città #
Chandler 7.378
Singapore 7.286
Wilmington 6.854
San Mateo 2.586
The Dalles 2.292
Ashburn 1.629
Ann Arbor 1.402
Shanghai 1.381
Helsinki 1.373
Leawood 1.222
Lawrence 1.117
Princeton 1.117
Dublin 1.062
Boardman 1.009
Benin City 911
San Jose 867
Fairfield 684
New York 648
Woodbridge 647
Ho Chi Minh City 638
Dallas 618
Paris 576
Hanoi 532
Amsterdam 394
Hong Kong 392
Seattle 366
San Diego 316
Beijing 271
London 246
Toronto 214
São Paulo 213
Los Angeles 167
Norwalk 128
Milan 109
Da Nang 108
Kocaeli 103
Haiphong 86
Rio de Janeiro 85
Santa Clara 81
Falkenstein 80
Belo Horizonte 71
Phoenix 63
Brooklyn 55
Warsaw 55
Montreal 52
Baghdad 47
Tokyo 47
Johannesburg 45
Chicago 43
Dhaka 43
Houston 43
Orem 43
Brasília 42
Pune 41
Tashkent 41
Porto Alegre 39
Moscow 38
Reston 36
Stockholm 35
Nairobi 34
Hải Dương 33
Campinas 31
Chennai 31
Hillsboro 30
Monmouth Junction 30
Munich 30
Amman 29
Biên Hòa 29
Curitiba 29
Redmond 29
Buffalo 28
Des Moines 27
Boston 26
Frankfurt am Main 26
Mexico City 25
Istanbul 24
Charlotte 23
Manchester 23
Ribeirão Preto 22
Salvador 22
Lahore 21
Can Tho 20
Council Bluffs 20
Erbil 20
Fortaleza 20
New Delhi 20
Quito 20
Guarulhos 19
Asunción 18
Buenos Aires 18
Denver 18
Nha Trang 18
Phủ Lý 18
San Francisco 18
Baku 17
Goiânia 17
Riyadh 17
Cape Town 16
Caracas 16
Hangzhou 16
Totale 49.015
Salva come PNG Salva come JPEG
Nome #
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 118
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 115
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 110
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 105
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 103
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 102
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 99
7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY 98
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 97
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 97
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 97
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 96
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 96
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 94
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 94
[F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging 94
3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients 94
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 93
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 93
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 93
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 92
18F-FDG PET/CT in Detecting Metastatic Infection in Children 92
Kidney protection during peptide receptor radionuclide therapy (PRRT) 91
F-18-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia 91
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 91
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 91
18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy 91
PET-CT for response assessment and treatment adaptation in head and neck cancer 90
New targeted probes for radioimaging of angiogenesis 90
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 90
FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma 90
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 90
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 89
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 89
99mTc-interleukin-8 for imaging acute osteomyelitis 89
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 89
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 89
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 88
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 88
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 88
A 3-step pretargeting strategy to image infection 88
In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages 88
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 88
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 88
The role of megalin in the renal uptake of radiolabeled peptides 87
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 87
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 87
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 86
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 86
Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo 86
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 86
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 86
Clinical application of FDG-PET/CT in metastatic infections 86
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 85
Progress in nuclear medicine procedures in head and neck oncology 85
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 85
PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis 85
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody 85
Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area 85
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 84
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 84
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 84
Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma 83
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 83
In-111-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib 83
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 83
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 83
F-18-FDG PET in detecting metastatic infectious disease 83
Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET 83
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study 83
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 82
EANM Focus 1: one small step for two men, one giant leap for a specialty 82
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 82
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 82
Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters. 82
Radiopharmaceuticals to image infection and inflammation 82
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes 82
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 81
Evaluation of a Ga-68-labelled Minigastrin for PET Imaging of CCK2/gastrin Receptor-Positive Tumours 81
SPECIFIC ANTIBODY UPTAKE IN TUBERCULOSIS 81
Molecular imaging of hypoxia 81
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results 81
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic F-18 Fluorodeoxyglucose PET 81
Radiolabeled IL-1ra for detection of synovitis in patients with RA. Preliminary results. 81
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 81
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring 80
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer 80
Radioimmunotheapy with [I-131]cG250 in patients with metastasized renal cell cancer: Dosimetric analysis and immunologic response 80
STERICALLY STABILIZED LIPOSOMES LABELED WITH IN-111 TO IMAGE FOCAL INFECTION 80
Ga-68-labelled exendin-3, a new agent for the detection of insulinomas with PET 80
Cost-effectiveness of Adding FDG-PET or CT to the Diagnostic Work-up of Patients With Stage III Melanoma 80
PET and SPECT Imaging of a Radio labeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu-64, Ga-68, and In-111 80
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise 79
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: a possibility to detect anastomotic leakage? A Pilot study 79
Quantitative Assessment of Heterogeneity in Tumor Metabolism Using FDG-PET 79
PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients 79
Spatial resolution of the Inveon small-animal PET scanner for the entire field of view 79
Imaging of cellular therapies 79
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 79
Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques 79
Totale 8.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 522.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 522.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.409 0 0 0 0 0 0 0 0 0 2.209 3 1.197
2021/20224.627 79 16 98 1.389 3 6 125 846 434 329 1.015 287
2022/202317.903 2.481 628 1.666 1.827 1.928 1.633 9 1.746 3.329 1.396 999 261
2023/20246.755 651 912 1.757 185 208 613 138 381 91 69 490 1.260
2024/20259.716 186 155 58 29 29 1.005 486 1.576 1.297 2.812 936 1.147
2025/202620.794 3.861 1.005 381 1.706 576 757 9.033 1.435 1.268 772 0 0
Totale 71.970